HBV-IN-41

HBV-IN-41

• CAS Number: 1967002-25-0
• UNSPSC Description: HBV-IN-41 (compound 45) is a potent and orally active Hepatitis B Virus (HBV) inhibitor, with an EC50 of 0.027μM[1].
• Target Antigen: HBV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/hbv-in-41.html
• Solubility: 10 mM in DMSO
• Smiles: C[C@H]1CN2C(CN1C(NC3=CC(Cl)=C(C=C3)F)=O)=C(C=N2)N4CCOCC4=O
• Molecular Weight: 407.83
• References & Citations: [1]Kou B, et al. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. J Med Chem. 2023 Oct 6.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported